Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial

Prostate Cancer Prostatic Dis. 2023 Dec;26(4):812. doi: 10.1038/s41391-023-00682-2.
No abstract available

Publication types

  • Published Erratum